Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) EBIT (2017 - 2025)

Neuronetics (STIM) has disclosed EBIT for 9 consecutive years, with -$5.0 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 56.04% to -$5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$31.4 million through Dec 2025, up 9.06% year-over-year, with the annual reading at -$31.4 million for FY2025, 9.05% up from the prior year.
  • EBIT for Q4 2025 was -$5.0 million at Neuronetics, up from -$7.3 million in the prior quarter.
  • The five-year high for EBIT was -$4.4 million in Q4 2023, with the low at -$11.5 million in Q4 2024.
  • Average EBIT over 5 years is -$8.0 million, with a median of -$7.6 million recorded in 2022.
  • The sharpest move saw EBIT crashed 196.29% in 2021, then soared 56.04% in 2025.
  • Over 5 years, EBIT stood at -$6.9 million in 2021, then fell by 11.84% to -$7.7 million in 2022, then soared by 42.71% to -$4.4 million in 2023, then crashed by 159.14% to -$11.5 million in 2024, then skyrocketed by 56.04% to -$5.0 million in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$5.0 million, -$7.3 million, and -$8.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.